Mariana Hernandez-Gonzalez

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

A critical residue in a conserved RBD epitope determines neutralization breadth of pan-sarbecovirus antibodies with recurring YYDRxxG motifs.

A critical residue in a conserved RBD epitope determines neutralization breadth of pan-sarbecovirus antibodies with recurring YYDRxxG motifs.

Journal: mBio
Published: July 31, 2025

A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.

A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.

Journal: Journal of virology
Published: November 04, 2024

Somatic hypermutation shapes the viral escape profile of SARS-CoV-2 neutralising antibodies.

Somatic hypermutation shapes the viral escape profile of SARS-CoV-2 neutralising antibodies.

Journal: EBioMedicine
Published: August 21, 2024

Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1.

Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1.

Journal: Frontiers in immunology
Published: April 12, 2023

Canine real-time detection of SARS-CoV-2 infections in the context of a mass screening event.

Canine real-time detection of SARS-CoV-2 infections in the context of a mass screening event.

Journal: BMJ global health
Published: July 28, 2022

Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity.

Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: June 13, 2022

An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern.

An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern.

Journal: Science immunology
Published: April 26, 2022

Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections-an Open Observational Study in Lower Saxony, Germany.

Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections-an Open Observational Study in Lower Saxony, Germany.

Journal: Microbiology spectrum
Published: February 16, 2022

SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.

SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.

Journal: Nature communications
Published: January 31, 2022

SARS-CoV-2-Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe.

SARS-CoV-2-Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe.

Journal: Emerging infectious diseases
Published: October 25, 2021

Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.

Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.

Journal: PloS one
Published: January 10, 2019

Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L.

Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L.

Journal: Virology
Published: January 09, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026